Vismed sodium hyaluronate opthalmic solution regulatory update

FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will meet on June 26 to discuss an NDA from Lantibio for Vismed to treat signs and symptoms of dry eye disease. Vismed is a 0.18% sodium hyal...